Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha

Veterinary Parasitology

Volumn 153, Issue 1-2, 2008, Pages 52-64

  McConville, M ^a   Brennan, G P ^a   Flanagan, A ^a   Edgar, H W J ^b   McCoy, M ^b   Castillo, R ^c   Hernandez Campos A ^c   Fairweather, I ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b AGRI FOOD AND BIOSCIENCES INSTITUTE   (United Kingdom)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Compound alpha; Electron microscopy; Experimental fasciolicide; Fasciola hepatica

Indexed keywords

COMPOUND ALPHA; FASCIOLICIDE; TRICLABENDAZOLE; UNCLASSIFIED DRUG;

ANIMAL EUTHANASIA; ARTICLE; AUTOPHAGY; BASEMENT MEMBRANE; CELL VACUOLE; CONTROLLED STUDY; DRUG MECHANISM; FASCIOLA HEPATICA; IN VIVO STUDY; ISOLATION PROCEDURE; LIVER; NONHUMAN; SCANNING ELECTRON MICROSCOPY; SHEEP; STRESS; SWELLING; SYNCYTIUM; TRANSMISSION ELECTRON MICROSCOPY; WORM TEGUMENT;

ANIMALS; ANTHELMINTICS; FASCIOLA HEPATICA; FASCIOLIASIS; GASTROINTESTINAL DISEASES; IMIDAZOLES; INTEGUMENTARY SYSTEM; NAPHTHALENES; SHEEP; SHEEP DISEASES;

FASCIOLA HEPATICA; OVIS ARIES;

EID: 41149121469     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2008.01.022     Document Type: Article

References (37)

1. Álvarez-Sánchez M.A., Mainar-Jaime R.C., Pérez-García J., and Rojo-Vázquez F.A. Resistance of Fasciola hepatica to triclabendazole and albendazole in sheep in Spain. Vet. Rec. 156 (2006) 424-425
2. Anderson H.R., and Fairweather I. Fasciola hepatica: ultrastructural changes to the tegument of juvenile flukes following incubation in vitro with the deacetylated (amine) metabolite of diamphenethide. Int. J. Parasitol. 25 (1995) 319-333
3. Anon. Resistance to fluke drug found on Sligo farm. Irish Farmers' J. 2 March 18 (1995)
4. Anon. Report of the Scottish Agricultural College's Veterinary Science Division. Vet. Rec. 143 (1998) 653-654
5. Boray J.C. Disease of Domestic Animals Caused by Flukes (1994), Food and Agricultural Organisation of the Untied Nations, Rome 49 pp
6. Carr A.W., McCracken R.O., and Stillwell W.H. Uncoupling of rat liver mitochondria oxidative phosphorylation by the fasciolicide triclabendazole and its sulfoxide and sulfone metabolites. J. Parasitol. 79 (1993) 198-204
7. Fairweather I., Threadgold L.T., and Hanna R.E.B. Development of Fasciola hepatica in the mammalian host. In: Dalton J.P. (Ed). Fasciolosis (1999), CAB International, Wallingford 47-111
8. Gaasenbeek C.P.H., Moll L., Cornelissen J.B.W.J., Vellema P., and Borgsteede F.H.M. An experimental study on triclabendazole resistance of Fasciola hepatica in sheep. Vet. Parasitol. 95 (2001) 37-43
9. Hanna R.E.B. Fasciola hepatica: glycocalyx replacement in the juvenile as a possible mechanism for protection against host immunity. Exp. Parasitol. 50 (1980) 103-114
10. Hernández-Campos A., Ibarra-Velarde F., Vera-Montenegro Y., Rivera-Fernandez N., and Castillo R. Synthesis and fasciolicidal activity of 5-chloro-2-methylthio-6-(1-naphthyloxy)-1H-benzimidazole. Chem. Pharm. Bull. 50 (2002) 649-652
11. Ibarra V.F., García S.E., Fernández R.M., Vera M.Y., Castillo B.R., and Hernández C.A. Eficacia fasciolicida de dos compuestos de síntesis química in vitro e in vivo en ovinos. Vet. Méx. 8 (1997) 4-8
12. Ibarra V.F., Vera M.Y., Hernández C.A., and Castillo B.R. Eficacia fasciolicida del compuesto "alfa" contra estadios juveniles y adultos en ovinos. Vet. Méx. 28 (1997) 297-301
13. Ibarra V.F., Montenegro C.N., Flores C.J., Hernández C.A., and Castillo B.R. Evaluación de cuatro vehículos para formular un fasciolicida experimental. Vet. Méx. 31 (2000) 47-51
14. Lane G. Anthelmintic resistance. Vet. Rec. 143 (1998) 332
15. McConville M., Brennan G.P., McCoy M., Castillo R., Hernandez-Campos A., Ibarra F., and Fairweather I. Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha. Parasitology 133 (2006) 195-208
16. McConville M., Brennan G.P., McCoy M., Castillo R., Hernandez-Campos A., Ibarra F., and Fairweather I. Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha. Parasitol. Res. 100 (2007) 365-377
17. McCoy M.A., Fairweather I., Brennan G.P., Kenny J.M., Ellison S., and Forbes A.B. The efficacy of nitroxynil and triclabendazole administered synchronously against juvenile triclabendazole-resistant Fasciola hepatica in sheep. Res. Vet. Sci. 78 Suppl. A (2005) 33
18. McCoy M.A., McConville M., Brennan G.P., Kenny J.M., Edgar H.W.J., Ellison S., Flanagan A., Meaney M., Gordon A.W., and Fairweather I. The efficacy of the experimental flukicide, compound alpha against triclabendazole-resistant Fasciola hepatica infections in sheep. Proceedings of the Eleventh International Congress of Parasitology. Glasgow, Scotland (2006) a1247
19. McKinstry B., Brennan G.P., Halferty L., Forbes A.B., and Fairweather I. Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax). Parasitol. Res. 101 (2007) 929-941
20. Meaney M., Allister J., McKinstry B., McLaughlin K., Brennan G.P., Forbes A.B., and Fairweather I. Fasciola hepatica: ultrastructural effects of a combination of triclabendazole and clorsulon against mature fluke. Parasitol. Res. 100 (2007) 1091-1104
21. Mitchell G.B.B., Maris L., and Bonniwell M.A. Triclabendazole-resistant liver fluke in Scottish sheep. Vet. Rec. 143 (1998) 399
22. Moll L., Gaasenbeek C.P.H., Vellema P., and Borgsteede F.H.M. Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in the Netherlands. Vet. Parasitol. 91 (2000) 153-158
23. Mottier L., Alverez L., Ceballos L., and Lanusse C. Drug transport mechanisms in helminth parasites: passive diffusion of benzimidazole anthelmintics. Exp. Parasitol. 113 (2006) 49-57
24. Overend D.J., and Bowen F.L. Resistance of Fasciola hepatica to triclabendazole. Aust. Vet. J. 72 (1995) 275-276
25. Rivera F.N., Ibarra V.F., Olazaràn J.S., Vera M.Y., Castillo B.R., and Hernández C.A. Efficacy of 5-chloro-2-methylthio-6-(1-naftiloxi)-ih-benzimidazole against different stages of Fasciola hepatica in Pelibuey sheep. Vet. Méx. 33 (2002) 55-61
26. Rivera N., Ibarra F., Zepeda A., Fortoul T., Cantó G., Hernández A., and Castillo R. The effect of the 5-chloro-2-methylthio-6-(1-naphtyloxy)-H-benzimidazole on the tegument of immature Fasciola hepatica in their natural host. Parasitol. Res. 95 (2005) 379-382
27. Rivera N., Ibarra F., Zepeda A., Fortoul T., Hernández A., Castillo R., and Cantó G. Tegumental surface changes in adult Fasciola hepatica following treatment in vitro and in vivo with an experimental fasciolicide. Parasitol. Res. 93 (2004) 283-286
28. Rivero L.M., Jung H., Castillo R., and Hernández-Campos A. High-performance liquid chromatographic assay for a new fasciolicide agent, α-BIOF10, in biological fluids. J. Chromatogr. B. 712 (1998) 237-241
29. Robinson M.W., Trudgett A., Hoey E.M., and Fairweather I. Triclabendazole-resistant Fasciola hepatica: β-tubulin and response to in vitro treatment with triclabendazole. Parasitology 124 (2002) 325-338
30. Robinson M.W., Trudgett A., Hoey E.M., and Fairweather I. The effect of the microtubule inhibitor tubulozole-C on the tegument of triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica. Parasitol. Res. 91 (2003) 117-129
31. Stitt A.W., and Fairweather I. Spermatogenesis in Fasciola hepatica: an ultrastructural comparison of the effects of the anthelmintic, triclabendazole ("Fasinex") and the microtubule inhibitor, tubulozole. Invert. Reprod. Dev. 22 (1992) 139-150
32. Stitt A.W., and Fairweather I. Fasciola hepatica: disruption of the vitelline cells in vitro by the sulphoxide metabolite of triclabendazole. Parasitol. Res. 82 (1996) 333-339
33. Stitt A.W., Fairweather I., and Mackender R.O. The effect of triclabendazole ("Fasinex") on protein synthesis by the liver fluke, Fasciola hepatica. Int. J. Parasitol. 25 (1995) 421-429
34. Thomas I., Coles G.C., and Duffus K. Triclabendazole-resistant Fasciola hepatica in southwest Wales. Vet. Rec. 146 (2000) 200
35. Vera Montenegro Y., Ibarra Velarde F., Quiroz Romero H., Hernández Campos A., and Castillo R. Field trial on the efficacy of an experimental fasciolicide compared with some commercial compounds in naturally infected cattle. Parasitol. Res. 91 (2003) 1-4
36. Vera Y., Ibarra F., Canto G.J., Soria O., Castillo R., and Hernàndez A. Determination of the maximum tolerated dose and the safety index of an experimental fasciolicide in cattle. J. Vet. Med. B 53 (2006) 145-149
37. Vera Montenegro Y., Ibarra Velarde F., Liébano Hernàndez E., Quiroz Romero H., Castillo Bocanegra R., Hernández Campos A., and Ochoa Galván P. Efficacy of an experimental fasciolicide against immature and mature Fasciola hepatica in artificially infected calves. Parasitol. Res. 92 (2004) 211-214